Method of treating non-insulin dependent diabetes mellitus with phytanic acid derivatives
View Patent ↗The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
1. A method of treating non-insulin dependent diabetes mellitus comprising administering to a human or an animal a pharmaceutical composition or a dietary supplement comprising from about 0.1 to about 1000 mg of phytanic acid or a derivative of phytanic acid in an effective dose to treat said non-insulin dependent diabetes mellitus, wherein said derivative of phytanic acid is selected from the group consisting of phytanic esters, phytanic amides, hydroxy-phytanic esters, hydroxy-phytanic amides, hydroxy-phytenic acid, and combination thereof.
2. A method according to claim 1 , wherein the effective dose is from about 0.1 to about 500 mg.
3. A method according to claim 1 , wherein the effective dose is from about 0.1 to about 100 mg.
4. A method according to claim 1 , wherein the effective dose results in a daily dose of the phytanic acid of about 0.1 to about 50 mg/kg body weight.
5. A method according to claim 1 , wherein the effective dose results in a daily dose of the phytanic acid of about 0.5 to about 40 mg/kg/day.
6. A method according to claim 1 , wherein the effective dose results in a daily dose of the phytanic acid of about 1.0 to about 20 mg/kg/day.